Abstract: There is provided a method of design and analysis of a geometric object comprising: receiving an initial definition of the geometric object in a coordinate system; generating a volumetric model according to the initial definition, the volumetric model comprises: volumetric cells each represented by one or more multivariate of three variables or more functions, and intra object general border surfaces in general orientation each defines topological adjacency between at least two of said plurality of volumetric cells.
Type:
Application
Filed:
May 24, 2017
Publication date:
May 2, 2019
Applicant:
Technion Research & Development Foundation Limited
Abstract: A ground-based satellite control station to control an array of nanosatellites in low earth orbit to produce an illumination event visible at a predetermined ground location. The nanosatellites in the array may have an illumination element, and array of nanosatellites in low earth orbit (LEO) may controllably apply their illumination to be visible on the ground. The nanosatellites may be coordinated by the control station to provide illumination events visible on the ground at particular locations and particular times.
Type:
Application
Filed:
December 13, 2018
Publication date:
April 25, 2019
Applicant:
Technion Research & Development Foundation Limited
Abstract: A nanosatellite with an illumination element, and an arrangement of nanosatellites in low earth orbit (LEO) arranged to controllably apply their illumination to be visible on the ground. The nanosatellites may be coordinated to provide illumination events visible on the ground at particular locations and particular times.
Type:
Application
Filed:
December 13, 2018
Publication date:
April 25, 2019
Applicant:
Technion Research & Development Foundation Limited
Abstract: The present invention relates to heparanase-neutralizing monoclonal antibodies (m Abs), pharmaceutical composition comprising same, and use thereof for treating a disease or disorder associated with heparanase activity, including but not limited to cancer, inflammation, diabetes and related complications. The present invention further provides combined therapies comprising the heparanase-neutralizing m Ab and an anti-cancer treatment such as chemotherapy or radiation, for treating a proliferative disease in a subject.
Type:
Application
Filed:
October 13, 2016
Publication date:
April 18, 2019
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Israel VLODAVSKY, Marina WEISSMANN, Neta ILAN, Gil ARVATZ
Abstract: A transistor device is described, the transistor comprising: a channel region in contact with the gate insulator and source and drain electrodes in contact with the channel region and arranged in a spaced-apart relationship. The channel region is configured with discontinuity in a material path of the channel, located between the source and drain electrodes. The channel being formed by a plurality of discrete semiconductor particles, distributed irregularly within the channel region, and a plurality of electrically conducting particles. The electrically conducting particles connect at least some of said semiconducting particles to one another to provide continuous path for electric coupling between said at least some semiconductor particles, forming an electrical path between the source and drain electrodes.
Type:
Grant
Filed:
March 31, 2016
Date of Patent:
April 16, 2019
Assignee:
Technion Research & Development Foundation Limited
Abstract: Provided is a formulation including an agriculturally acceptable carrier and liposomes including a lipid membrane and an intraliposomal aqueous core. The liposome has a diameter in the range of between 100 nm to 300 nm and the lipid membrane includes at least one liposome forming phospholipid. The lipid membrane may include two or more phospholipids. At least one of the two or more phospholipids may be a liposome forming lipid. Further, at least one of the two or more phospholipids may be characterized by one or more of the following features: (a) it has an unsaturated lipid tail; (b) it includes a polar head group; (c) it includes an acidic head group. Further provided are methods of using the formulation for agricultural treatment and kits for preparing and using such formulations.
Type:
Application
Filed:
March 8, 2017
Publication date:
April 4, 2019
Applicant:
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
Abstract: A secure parallel processing technique for converting any parallel random access machine (PRAM) into an oblivious parallel random access machine (OPRAM), whose distribution of memory accesses is statistically independent of the data (with negligible error), while only inducing a polylogarithmic slowdown to both the total and parallel complexities of the program.
Type:
Grant
Filed:
July 31, 2015
Date of Patent:
April 2, 2019
Assignees:
Cornell University, Technion Research & Development Limited, Academia Sinica
Inventors:
Rafael Pass, Elette Boyle, Kai-Min Chung
Abstract: The present invention relates to metal micron-sized single crystals having a controlled curvature, which can be either fully or partially nanoporous; and to a process for growing of such single crystals from the confined volume of droplets of a eutectic composition melt comprising said metal as one of the two eutectic components, with no need of any fabrication steps.
Abstract: The present invention is of methods of establishing and propagating human embryonic stem cell lines using feeder cells-free, xeno-free culture systems and stem cells which are capable of being maintained in an undifferentiated, pluripotent and proliferative state in culture which is free of xeno contaminants and feeder cells.
Type:
Application
Filed:
September 3, 2018
Publication date:
March 28, 2019
Applicant:
Technion Research & Development Foundation Limited
Abstract: Provided are methods of predicting responsiveness of a subject having an inflammatory bowel disease (IBD) to a tumor necrosis factor (TNF)-alpha inhibitor, by analyzing a frequency of at least one subpopulation of immune cells in a tissue biopsy of the subject. Also provided are methods of selecting a treatment for a subject and kits for determining responsiveness of the subject to treatment with a TNF-alpha inhibitor.
Type:
Application
Filed:
April 6, 2017
Publication date:
March 28, 2019
Applicants:
Technion Research & Development Foundation Limited, The Board of Trustees of the Leland Stanford Junior University
Inventors:
Shai S. SHEN-ORR, Elina STAROVETSKY, Naama MAIMON, Purvesh KHATRI, Renaud GAUJOUX, Francesco VALLANIA
Abstract: Chimeric polypeptides comprising a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3?-HSD), fused to a signal peptide moiety, polynucleotides encoding same, and compositions comprising at least one microorganism cell capable of secreting the chimeric polypeptide, are provided. Further provided are methods and kits for treating, preventing or ameliorating androgen-dependent disorders, including but not limited to androgenic alopecia.
Type:
Grant
Filed:
March 28, 2017
Date of Patent:
March 26, 2019
Assignee:
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.
Abstract: Provided are physico-chemical processes for continuous and simultaneous water disinfection, oxidation of off flavor agents, minimization of trihalomethane (THM) production, reduction of nitrate and nitrite production and oxidation of ammonia so as to remove nitrogen species, in saline (for example, seawater) based aquaculture systems. The aquaculture system may be any handling/storage/transport system, for example, recirculated aquaculture systems (RAS), for fish or other aquaculture species.
Type:
Application
Filed:
March 8, 2017
Publication date:
March 21, 2019
Applicant:
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
Inventors:
Ori LAHAV, Raz BEN-ASHER, Youri GENDEL, Liat BIRNHACK
Abstract: A method of creating a real time synthetic model tracking a dynamic physical entity, comprising: a) Receiving multiple points extracted from a sequence of 3D information depicting a dynamic physical entity, each point is associated with position and photometric information. b) Identifying, within the multiply of points, a cloud point which includes multiple entity representative points which portray a surface of the dynamic physical entity. c) Generating a points-surface for a synthetic model by creating spatial presentation of the entity representative points through calculation of principal curvatures for each entity representative point according to the respective position information. d) Generating a continuous surface for the synthetic model by texturing ellipsoidal shapes created for each entity representative point according to the respective photometric information.
Type:
Application
Filed:
November 12, 2018
Publication date:
March 14, 2019
Applicant:
Technion Research & Development Foundation Limited
Abstract: A system comprising: a handheld mobile device comprising: a projector unit configured to project an image; a camera; and a prism configured to reflect the image projected by the projector such that the camera can capture the projected image.
Type:
Grant
Filed:
April 7, 2015
Date of Patent:
March 5, 2019
Assignee:
Technion Research and Development Foundation Limited
Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Type:
Application
Filed:
November 14, 2018
Publication date:
February 28, 2019
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Timor Baasov, Tamar Ben-Yosef, Igor Nudelman, Annie Rebibo-Sabbah, Dalia Shallom-Shezifi, Mariana Hainrichson
Abstract: Provided is an isolated population of human pluripotent stem cells comprising at least 50% human pluripotent stem cells characterized by an OCT4+/TRA1-60?/TRA1-81?/SSEA1+/SSEA4? expression signature, and novel methods of generating and maintaining same in a pluripotent, undifferentiated state a suspension culture devoid of cell clumps. Also provided are novel culture media, cell cultures and methods for culturing pluripotent stem cells in a suspension culture or a two-dimensional culture system while maintaining the cells in a proliferative, pluripotent and undifferentiated state. The novel culture media comprise interleukin 11 (IL11) and Ciliay Neurotrophic Factor (CNTF); bFGF at a concentration of at least 50 ng/ml and an IL6RIL6 chimera; or an animal contaminant-free serum replacement and an IL6RIL6 chimera. Also provided are methods for generating lineage-specific cells from the pluripotent stem cells.
Type:
Grant
Filed:
September 7, 2011
Date of Patent:
February 26, 2019
Assignee:
Technion Research & Development Foundation Limited
Abstract: An apparatus for pad printing includes a printing pad (12). A textured transfer member (13) is configured to be pressed alternately by the printing pad (12) against an ink carrier (17) and against a substrate (24) so as to transfer an ink pattern to the substrate.
Type:
Grant
Filed:
August 24, 2014
Date of Patent:
February 12, 2019
Assignee:
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
Abstract: A microparticle for cell encapsulation is provided, having a core which comprises continuous fibers of decellularized extracellular matrix (ECM) and, optionally, an outer layer. Also provided are methods of encapsulating cells in the microparticle, pharmaceutical compositions comprising the microparticle, and methods of treating disease in animals employing the microparticles of the invention, for example, treating Diabetes.
Type:
Application
Filed:
September 25, 2018
Publication date:
January 24, 2019
Applicant:
Technion Research & Development Foundation Limited
Abstract: The present disclosure provides a delivery system comprising (i) a physiologically acceptable carrier and (ii) a proteolytic enzyme or effector thereof for use in a method for relaxing fibers within a subject's oral cavity. In some embodiments, the relaxation is for use in tooth manipulation (particularly repositioning). In some embodiments, the method involves the use of the proteolytic enzyme or effector thereof at a concentration effective to cause relaxation of fibers between the tooth's alveolar bone and gingiva while maintaining integrity of the fibers surrounding the tooth. Also disclosed herein are methods for fiber relaxation and/or repositioning of tooth making use of the proteolytic enzyme or effector thereof.
Type:
Grant
Filed:
March 19, 2015
Date of Patent:
January 22, 2019
Assignee:
TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
Inventors:
Avraham D. Schroeder, Assaf Yosef Zinger, Avishay Herman
Abstract: Novel aminoglycosides, represented by Formulae Ia and Ib, as defined in the instant specification, are disclosed. Also disclosed are pharmaceutical compositions containing the same, and uses thereof in the treatment of medical conditions associated with a pathogenic microorganism.
Type:
Application
Filed:
September 2, 2016
Publication date:
January 17, 2019
Applicant:
Technion Research & Development Foundation Limited